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embryos (Saint-Jeannet et al., 1997; LaBonne and Bron-
ner-Fraser, 1998; Deardorff et al., 2001). Moreover, tran-
scriptional mediators of Wnt signaling appear to act
Summary
directly on the promoter of at least one early marker of
neural crest precursor cells (slug; Vallin et al., 2001).
The neural crest, a population of multipotent progeni- More recently, it has been demonstrated that Wnts are
tor cells, is a defining feature of vertebrate embryos. likely to function as endogenous neural crest inducers
Neural crest precursor cells arise at the neural plate in avian embryos (Garcia-Castro et al., 2002). It is impor-
border in response to inductive signals, but much re- tant to note, however, that, at least in Xenopus, Wnt
mains to be learned about the molecular mechanisms signals do not appear to be specifically instructive of
underlying their induction. Here we show that the pro- neural crest fates. Although inhibitors of Wnt signaling
tooncogene c-Myc is an essential early regulator of prevent neural crest formation in Xenopus embryos, they
neural crest cell formation in Xenopus. c-myc is local- also prevent the formation of other cell types at the
ized at the neural plate border prior to the expression neural plate border, including Rohon-Beard cells, a pop-
of early neural crest markers, such as slug. A morpho- ulation of CNS-derived sensory neurons (Bang et al.,
lino-mediated “knockdown” of c-Myc protein results 1999). Thus, additional signals must direct a subset of
in the absence of neural crest precursor cells and a cells at the neural plate border to form neural crest
resultant loss of neural crest derivatives. These effects precursors. Recent work in zebrafish suggests that
are not dependent upon changes in cell proliferation notch signaling could play such a role, at least in spinal
or cell death. Instead, our findings reveal an important cord regions (Cornell and Eisen, 2002).
and unexpected role for c-Myc in the specification of Downstream of Wnts, the earliest known response to
cell fates in the early ectoderm. neural crest-inducing signals is the expression of the
zinc finger transcription factor slug (Mayor et al., 1995)
and/or the closely related factor snail (Essex et al., 1993).Introduction
These factors have been found to play an essential role
in both the initial formation of neural crest precursorNeural crest cells originate in the embryonic ectoderm
cells and the onset of neural crest migration (Nieto etat the border between the neural plate, which gives
al., 1994; Carl et al., 1999; LaBonne and Bronner-Fraser,rise to the central nervous system, and the nonneural
2000). In addition, Slug has been found to act as a posi-ectoderm, which generates the epidermis. Around the
tive effector of neural crest formation, as overexpressiontime of neural tube closure, neural crest cells migrate
of Slug in either Xenopus or chick embryos leads toextensively, ultimately giving rise to a diverse set of
an expansion of neural crest precursors (LaBonne andderivatives that includes much of the peripheral nervous
Bronner-Fraser, 1998; del Barrio and Nieto, 2002). Inter-system, melanocytes, and most of the craniofacial skel-
estingly, despite its ability to promote neural crest for-eton (Le Douarin and C. Kalcheim, 1999; Hall and Ho¨rs-
mation, Slug itself has been shown to function as atadius, 1988; LaBonne and Bronner-Fraser, 1999). In
transcription repressor (LaBonne and Bronner-Fraser,recent years, considerable progress has been made to-
2000; Mayor et al., 2000). These findings raise the ques-ward understanding some of the early events underlying
tion of whether neural crest “induction” is at its coreneural crest formation. The induction of neural crest
a repression of alternative fates or whether upstreamprecursors at the lateral edges of the neural plate is
transcriptional activators of this process also exist. Suchthought to be dependent on signals emanating from the
ambiguity highlights the fact that, despite recent prog-
nonneural ectoderm, the nonaxial mesoderm, or both
ress, much remains to be learned about the molecular
(reviewed in LaBonne and Bronner-Fraser, 1999). Evi-
mechanisms underlying the formation of the neural
dence from Xenopus and zebrafish suggests that inter- crest.
mediate levels of BMP signaling play an important role To identify additional early regulators of neural crest
in the specification of cell fates at the neural plate border formation, we have carried out functional and expres-
(Wilson et al., 1997; LaBonne and Bronner-Fraser, 1998; sion pattern-based screens of arrayed cDNA libraries.
Marchant et al., 1998; Nguyen et al., 1998); however, These screens have identified a number of cDNAs that
these signals alone are not sufficient to mediate neural are expressed in the neural crest from early stages of
crest formation (Wilson et al., 1997; LaBonne and Bron- its development. One of these cDNAs, which is ex-
ner-Fraser, 1998). Instead, neural crest induction is pressed at the neural plate border from mid-gastrula
stages, was found to encode the protooncogene c-Myc,
a basic helix-loop-helix zipper (bHLHZ) transcription*Correspondence: clabonne@northwestern.edu
Developmental Cell
828
factor that has been implicated in diverse cellular events, in a rostral to caudal wave beginning in the anterior-
most (mandibular) neural crest precursors and continu-such as cell growth, proliferation, apoptosis, and differ-
ing through more-caudal cranial regions (hyoid andentiation. Because of the extremely early onset of its
branchial crest) into spinal cord regions. At all axial lev-expression at the neural plate border and its known
els, cells were observed to first express c-myc and onlyparticipation in important cellular process in other sys-
subsequently to express slug. Interestingly, the domaintems, c-Myc was an excellent candidate for an upstream
of cells expressing c-myc was broader than the subse-regulator of neural crest formation. Using morpholino
quent domain of slug expression and appeared to in-oligo-mediated depletion, we show here that c-Myc is
clude cells lateral to those that will ultimately form neuralrequired for the initial induction of neural crest precur-
crest cells. This was further demonstrated by double insors and further demonstrate that c-Myc-depleted em-
situ hybridization experiments comparing the expres-bryos lack neural crest derivatives. Interestingly, we find
sion of c-myc and slug at stage 12.5 (Figure 1E). Al-that c-Myc depletion does not alter the proliferation of
though the onset of c-myc expression at the neural plateneural crest precursors. Instead, we demonstrate a cen-
border is first observed at mid-gastrula stages, weaktral role for c-Myc as a key regulator of cell fate decisions
expression of this gene can be detected in the animalin the early embryonic ectoderm.
hemisphere of cleavage and blastula stage embryos
(data not shown). Indeed, previous studies have demon-
strated that c-myc is expressed maternally from oocyteResults
stages (Vriz et al., 1989), and these findings were con-
firmed by Northern blot analysis (Figure 1C). Taken to-c-Myc Is an Early Marker of Neural Crest
gether, these results led us to speculate that c-MycPrecursor Cells
could play a very early role in the formation of neuralAn expression pattern-based screen of an arrayed early
crest precursor cells.neurula stage cDNA library identified a cDNA that was
We and others have previously shown that Wnt signalsexpressed in three distinct regions of early neurula stage
are essential upstream mediators of slug expression inembryos (Figure 1A). At stage 14, the strongest expres-
neural crest precursor cells (Saint-Jeannet et al., 1997;sion of this gene was observed at the lateral edges of
LaBonne and Bronner-Fraser, 1998; Deardorff et al.,the rising neural folds in mid- and hindbrain regions, in
2001). A number of studies have also suggested thatcells that are fated to give rise to neural crest. Expression
c-Myc is a target of the Wnt signaling pathway in otherwas also noted in the transverse neural fold, the only
systems (He et al., 1998; Willert et al., 2002). We thereforeregion of the neural plate border that does not contribute
asked whether the expression of c-Myc at the neuralto the neural crest. The expression in the transverse
plate border was Wnt dependent. Embryos were in-neural fold was found to correspond to a region of cells
jected in one cell at the two-cell stage with mRNA encod-that also express the transcription factor pax6 (Figure
ing a dominant-negative Wnt ligand (Hoppler et al.,1B), which marks the precursors of a variety of essential
1996), and c-Myc expression was examined at mid-gas-cell types, including the retinal and olfactory primordia,
trula stages by in situ hybridization. Blocking Wnt sig-the telencephalon, and portions of the diencephalon
nals was found to prevent expression of c-myc in neural(Hirsch and Harris, 1997). A third region of expression
crest-forming regions as early as stage 11.5 (Figure 1F;in the posterior of the embryo was also noted, delineat-
92%, n  32), placing c-Myc expression between Wnting cells that will ultimately give rise to the tailbud (Figure
activation and slug induction in the known hierarchy1A). When the library clone exhibiting this expression
of regulatory events leading to neural crest formation.pattern was isolated and sequenced, it was found to
Interestingly, overexpression of dominant-negative Wntencode the Xenopus ortholog of the protooncogene
was also found to block c-myc expression in the trans-c-Myc. This bHLHZ transcription factor has been impli-
verse neural fold (data not shown), suggesting that the
cated in a variety of important cellular events in other
role of Wnt signals in patterning the neural plate border
systems, including cell proliferation, apoptosis, and dif-
is not restricted to posterior cell types.
ferentiation (Grandori et al., 2000; Eisenman, 2001), sug- We next wished to determine whether, consistent with
gesting a number of intriguing possibilities for how it its expression pattern, c-Myc is an important regulator
could regulate neural crest development. Importantly, of neural crest formation. However, c-Myc is a member
the striking expression of c-Myc in neural crest precur- of a multigene family that includes the closely related
sors is not restricted to anamniote embryos, as we find factors N-Myc and L-Myc (Grandori et al., 2000; Eisen-
analogous domains of expression in early chick em- man, 2001). The interpretation of loss-of-function exper-
bryos (see Supplemental Figure S1 at http://www. iments could therefore be complicated if related family
developmentalcell.com/cgi/content/full/4/6/827/DC1). members are coexpressed and have overlapping func-
Because of the early onset of c-myc expression in tions. This is particularly true of N-Myc, which has been
lateral, neural crest-forming regions of the neural plate implicated in the regulation of later stages of neural crest
border, its expression was compared to that of slug, development in avian embryos (Wakamatsu et al., 1997).
one of the earliest known markers of this region (Mayor We therefore used RT-PCR to examine the expression
et al., 1995). We found that c-myc expression could be of N-myc and L-myc in Xenopus embryos during the
detected in presumptive mandibular neural crest precur- course of neural crest development. Expression of
sor cells from mid-gastrula stages (Nieuwkoop and L-myc was not detected at any of the stages examined
Faber stage 11), several hours earlier than the onset of (Stage 7 through tailbud; data not shown), consistent
slug expression in this region (Figure 1D). The expres- with previous observations (Schreiber-Agus et al., 1993).
In contrast, expression of N-myc could be detected fromsion of early neural crest markers such as slug proceeds
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Figure 1. c-myc Expression Precedes slug Expression in Neural Crest Precursor Cells
(A) Anterior and posterior view of c-myc expression in a stage 14 embryo. Strong expression is seen in the anterior neural fold (anterior) and
around the closing blastopore (posterior).
(B) Comparison of c-myc and pax6 expression in the anterior neural fold.
(C) Northern analysis shows that c-myc is expressed both maternally and zygotically.
(D) Temporal comparison of c-myc and slug expression. c-myc expression in neural folds can be detected by mid-gastrula stages (stage 11).
(E) Double in situ showing blue cells expressing c-myc alone (white arrowhead) and purple cells coexpressing c-myc and slug (black arrowhead).
The domain of c-myc expression is wider than the region that also expresses slug.
(F) Overexpression of a dominant-negative Wnt ligand prevents c-myc expression (arrowhead).
early neural plate stages. In situ hybridization was used antisense oligonucleotides (MOs) that target c-Myc tran-
scripts. These MOs effectively block translation ofto compare the spatial distribution of c-myc and N-myc
transcripts (Figure 2). N-myc expression at neurula c-Myc from exogenous mRNAs injected into early Xeno-
stages was confined to a subset of presumptive CNS pus embryos (Figure 3A) or added to reticulocyte lysates
progenitor cells (Figures 2A and 2B), making c-myc the (data not shown). In contrast, a number of control MOs
only Myc family member expressed at detectable levels had no effect on c-Myc translation (Figure 3A and data
in neural crest precursors at early stages of their devel- not shown). Conversely, although c-Myc MOs were
opment. By stage 23, N-myc expression could be de- found to be strong inhibitors of c-Myc translation, they
tected in migratory cranial neural crest cells, as pre- did not directly block the translation of mRNAs encoding
viously reported (Vize et al., 1990), whereas, by this other known neural crest regulators such as slug and
stage, the expression of c-myc is beginning to be down- twist (Figure 3B). Once it had been determined that
regulated (Figure 2D). At late migratory stages, N-myc c-Myc MOs could be used as potent tools for inhibiting
is strongly expressed by all neural crest cells as well c-Myc function in early embryos, these MOs were in-
as cells in the CNS and eye (Figure 2C). Importantly, jected, together with -galactosidase mRNA as a lin-
however, these experiments indicate that, during premi- eage tracer, into single cells of eight-cell stage embryos.
gratory stages, when events central to the formation of This allowed us to deplete c-Myc protein in neural crest-
neural crest precursor cells are ongoing, neither L-myc forming regions of the ectoderm on one side of the
nor N-myc is coexpressed with c-myc. embryo, with the other side of the embryo serving as
an internal control. When injected embryos were exam-
ined by in situ hybridization at neurula stages, the ex-c-Myc Is Required for the Formation of Neural
Crest Precursor Cells pression of all early neural crest markers examined,
including slug (n  183), twist (n  197), and foxd3In order to examine the development of neural crest cells
in c-Myc-depleted embryos, we generated morpholino (n  89), was significantly inhibited or abolished on the
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Figure 2. c-myc, but Not N-myc, Is Expressed in Premigratory Neural Crest Cells
In situ hybridization was used to compare the temporal and spatial relationship between c-myc and N-myc expression at stages 13 (A), 16
(B), 23 (D), and 27 (C). At premigratory neural crest stages (A and B), only c-myc is expressed in neural crest cells. Expression of N-myc at
these stages is restricted to a small number of cells in the presumptive CNS.
injected side (Figures 3Ci–3Ciii, arrowheads). Expres- When c-Myc-depleted embryos were allowed to devel-
op to these stages, the expression of sox10 in cranialsion of these markers was inhibited from the earliest
stages at which their expression could be detected by neural crest cells was absent or greatly reduced (Figures
4A and 4B; 91%, n  87), consistent with the observedin situ hybridization (Figure 3C and data not shown).
We confirmed that the effects of the c-Myc MO were loss of neural crest markers at neurula stages (Figures
3C and 3D). In marked contrast, however, the expressionspecific by carrying out rescue experiments. c-Myc MO-
dependent loss of neural crest-specific gene expression of sox10 in CNS-derived glia and in the developing ear
was largely unaffected in c-Myc-depleted embryos (Fig-could by rescued by coinjecting a c-Myc mRNA lacking
the MO target sequence (compare Figures 3Di and 3Diii; ure 4Bi ). In contrast to the observed loss of sox10-
expressing neural crest cells, small ectopic patches ofn32, 94%). Interestingly, the expression of early neural
crest markers could not be restored by coinjecting sox10 expression in presumptive CNS-derived glial cells
were sometimes observed on the injected side of themRNA encoding Slug (Figure 3ii; n  38), indicating that
c-Myc regulates the expression of essential down- embryo (Figure 4Bi, yellow arrow, and data not shown).
Importantly, however, both the developing ears and thestream targets other than Slug. It will be important to
determine what combination of factors can cooperate characteristic domains of sox10 expression in the CNS
were observed to be colinear on the injected and controlwith Slug to rescue neural crest development in c-Myc-
depleted embryos. In contrast to embryos injected with sides of these embryos (Figure 4Bi ). Similarly, the CNS-
derived stripes of Krox20 expression in rhombomeresc-Myc MOs, we found that embryos injected with control
MOs (Figure 3Fi; n  150, 98%) or MOs directed against 3 and 5 were unperturbed in c-Myc-depleted embryos,
while neural crest-derived expression of this gene in theN-Myc (Figure 3Fii–3Fiv; n 82, 100%) displayed normal
expression of neural crest markers at neurula stages. neural crest migrating from rhombomere 5 was absent
(Figure 4Bii; n  22, 100%). Moreover, at neural plateEmbryos injected with MOs targeting N-Myc did exhibit
neural crest defects at migratory neural crest stages stages, the expression of opl in presumptive otic plac-
odes also remained colinear on the control and injected(A.B. and C.L., unpublished data), consistent with both
our observation that N-Myc is expressed in the neural sides of the embryo (Figure 7Cii; n  18). When c-Myc
MOs were targeted to the mesoderm, somite size andcrest at these later stages (Figure 2) and with the pre-
viously described role for this factor in migratory neural morphology on the injected side of the embryo appeared
normal (Figure 4C; n  28). Together, these findingscrest cells in the chick (Wakamatsu et al., 1997).
In interpreting the effects of c-Myc depletion, we demonstrate that the phenotypic consequences of
c-Myc depletion are largely confined to neural crest-wished to ensure that the observed absence of neural
crest marker expression was due to a specific loss of derived structures and that the defects observed in
c-Myc-depleted embryos are not secondary to eitherneural crest precursors, and not an indirect conse-
quence of a developmental delay or failure of conver- defects in anterior-posterior patterning or to a develop-
mental delay. c-Myc MOs also inhibit the induction ofgence/extension on the injected side of the embryo. At
late neurula stages, the HMG box transcription factor neural crest markers in ectodermal explants coexpress-
ing Wnt-8 and chordin (Figure 4D), further reinforcingsox10 is expressed in migrating cranial neural crest cells,
as well as in the ear and in glia of the developing CNS that the role of c-Myc in neural crest development is
direct and that the loss of expression of these markers(Cheng et al., 2000; J.L and C.L., unpublished data).
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Figure 3. c-Myc Is Required for Neural Crest Formation
(A) Western blot of embryo lysates demonstrating the efficiency of c-Myc MOs at inhibiting the translation of injected c-Myc mRNAs. RNA
and MO injections were sequential.
(B) Western blot of embryo lysates demonstrating that c-Myc MOs do not directly inhibit translation of other neural crest regulatory proteins.
(C) In embryos injected with c-Myc MOs, expression of the early neural crest markers slug, foxd3, and twist (purple) is inhibited on the injected
side, which is marked by -galactosidase staining (light blue, arrowhead).
(D) MO-mediated depletion of foxd3 expression (i ) can be rescued by injection of c-Myc transcripts lacking the MO target site (iii) but cannot
be rescued by slug (ii).
(E) N-Myc translation is inhibited by N-Myc MOs, but not c-Myc MOs, in IVT assays.
(F) Neither control MOs (i ) or N-Myc MOs (ii–v) block expression of the neural crest markers slug (i ), twist (ii), foxd3 (iii), or sox10 (iv) on the
injected side (arrowhead) of neurula stage embryos.
in c-Myc-depleted embryos is unlikely to be an indirect c-Myc-depleted embryos was comparable to that ob-
served in control explants (data not shown).consequence of blocking c-Myc function at an earlier
As a third measure of cell proliferation, we examinedstage of development.
the relative size of c-Myc-depleted cells and control
cells in regions of the ectoderm that form neural crest.
c-Myc Regulates Cell Fate Decisions In early Xenopus embryos there is no cell growth prior
in the Early Ectoderm to cell division, and, consequentially, cells get smaller
As c-Myc has been implicated in the control of cell with each cell cycle. Because of this, a decrease in
proliferation in other systems (Grandori et al., 2000; the rate of proliferation is accompanied by a relative
Eisenman, 2001), we wished to determine whether the increase in cell size. In order to compare the size of
observed loss of neural crest gene expression derived neural plate border cells that did or did not receive c-Myc
from a simple failure of neural crest precursors to be MOs, we injected two-cell Xenopus embryos with mRNA
induced or from the failure of a small induced population encoding a membrane-localized variant of GFP. This
of progenitor cells to proliferate and expand. To this allowed us to readily visualize cell size by confocal mi-
end, we examined the spatial distribution of cells immu- croscopy. At the 16-cell stage, a single GFP-labeled
noreactive to the mitosis marker phosphohistone H3 in cell was further injected with a mixture of rhodamine-
the neural folds of c-Myc-depleted embryos. No signifi- conjugated dextran and c-Myc MOs. When doubly la-
cant difference was noted in the numbers of actively beled embryos were examined at neural plate stages,
cycling cells in regions of the neural folds that did or did when premigratory neural crest precursors are present,
not receive c-Myc MOs (Figure 5A). Similarly, in another we found no difference in size between cells that did or
measure of cell division activity, the extent of BrdU in- did not receive the MOs (Figure 5B). Together with the
phosphohistone H3 and BrdU results, these findingscorporation in explants derived from gastrula stage
Developmental Cell
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Figure 4. c-Myc Depletion Does Not Perturb
A/P Patterning
(A) Expression of sox10 in migratory cranial
neural crest cells ([i], arrows) is absent on the
c-Myc-depleted side of the embryo (ii).
(B) (i ) Expression of sox10 in the ear (arrows)
and CNS is unperturbed on the c-Myc-
depleted side of embryos (red arrowhead)
and remains colinear with expression on the
control side (white arrowhead). (ii) Expression
of krox20 in migratory neural crest cells is
absent on the injected side of the embryo
(black arrow), while expression in the CNS is
unperturbed. CNS expression remains colin-
ear with the uninjected side.
(C) In situ hybridization with a muscle actin
probe demonstrates that c-Myc MOs tar-
geted to the mesoderm (ii) do not perturb
somite development.
(D) RT-PCR analysis in ectodermal explants
of embryos injected with neural crest-induc-
ing doses of Wnt and chordin. c-Myc MOs
inhibit the expression of the neural crest
markers slug, twist, and snail. L32 expression
serves as a loading control.
indicated that the rate of cell proliferation had not been were surprisingly normal (compare Figures 5Ci and 5Cii
with 5Cv and 5Cvi), not unlike what has previously beenappreciably altered by the extent of c-Myc depletion
achieved by the morpholino. described for CNS development (Harris and Hartenstein,
1991). We draw two conclusions from these data. First,In the course of demonstrating that the loss of neural
crest formation in c-Myc-depleted embryos is unlikely the early domains of neural crest formation at the lateral
edges of the neural plate have little dependence onto be due to effects on cell proliferation, we became
interested in understanding the extent to which prolifer- cell proliferation, but instead represent a recruitment of
surrounding ectoderm. Second, even if there were aation plays a mechanistic role in establishing the neural
crest-forming regions at the lateral edges of the neural decrease in cell proliferation in c-Myc-depleted em-
bryos that was not detected by our assays, this aloneplate. To examine this, we cultured embryos in the DNA
synthesis inhibitors hydroxyurea and aphidocolin from would not be sufficient to account for the observed loss
of neural crest marker expression at neurula stages.mid-gastrula stages, the time when c-myc expression
in neural crest precursors can be detected by in situ An alternative mechanism by which c-Myc depletion
could lead to a loss of neural crest precursors is byhybridization. We confirmed that proliferation had been
greatly decreased in these embryos by examining anti- activation of an apoptotic program. In most cases where
c-Myc has been implicated in the control of cell death,phosphohistone H3 immunoreactivity (Figure 5C). Inter-
estingly, when we examined the expression of neural it has been shown to possess proapoptotic activity (re-
viewed in Pelengaris et al., 2002). Nevertheless, therecrest markers in these embryos at mid-neurula stages,
we found that the domains of neural crest formation are examples in the literature in which c-myc expression
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has been found to correlate with protection from apo- evidence that neural crest cells fail to form in these
embryos. To confirm this, we allowed c-Myc-depletedptosis (Park et al., 2002; Russo et al., 2003). The contin-
embryos to develop to stages at which the formation ofued presence of large numbers of cells expressing -gal
neural crest derivatives could be evaluated. Embryosthroughout the development of c-Myc-depleted em-
were injected bilaterally at the eight-cell stage to primar-bryos suggested that there was unlikely to be wholesale
ily target spinal cord neural crest. When examined atloss of c-Myc-depleted cells in these embryos. Never-
swimming tadpole stages, these embryos were foundtheless, to address the possibility of neural crest death,
to be deficient in neural crest derivatives characteristicwe asked whether blocking apoptosis could rescue neu-
of this region, including the dorsal fin and melanocytes,ral crest precursor formation in c-Myc-depleted em-
but were otherwise morphologically normal (Figure 6Ai;bryos. No significant rescue of slug or foxd3 expression
n  85, 92%). In contrast, embryos in which c-Myc MOswas observed in embryos coinjected with mRNA encod-
had been targeted to cranial regions displayed normaling the anti-apoptotic factor Bcl-XL (85% reduced, n 
dorsal fin and trunk melanocyte development, while40) compared with embryos injected with the c-Myc MO
head development was clearly perturbed (Figure 6Aii;alone (82%, n  32) (Figure 5D and data not shown).
n  104, 95%).Moreover, we saw no significant increase in TUNEL la-
To examine the cranial phenotype more closely, webeling in c-Myc-depleted embryos at early neurula
generated embryos in which c-Myc depletion was con-stages, when the loss of neural crest marker expression
fined to cranial precursors on one side of the animal. Inis readily apparent (Figure 5Ei; n  61). In contrast,
a high percentage of these embryos (68%, n  107), ainjection of the known proapoptotic factor Dnmt3b1 (Ki-
mass of cells was observed adjacent to the neural tubemura et al., 2002) led to a significant loss of cells ex-
in hindbrain regions (Figure 6B). Many of these embryospressing the lineage tracer -gal and an increase in
had absent or reduced eyes (43%, n  107), suggestingTUNEL labeling at these stages (Figure 5Eii). The lack
that c-Myc function in the transverse neural fold (Figureof a pronounced effect of c-Myc depletion on either cell
1B) is required for normal eye development. Moreover,proliferation or apoptosis at neural plate stages sug-
morphologically distinct branchial arches were absentgested an alternative mechanism by which c-Myc could
on the injected side of these embryos (91%, n  107),influence neural crest precursor formation: by regulating
consistent with a failure of neural crest cells to migratecell fate decisions in the early ectoderm.
ventrally in the head to induce these structures. SinceDirect evidence for a role for c-Myc in regulating cell
neural crest cells in the branchial arches form the carti-fate decisions derived from experiments in which the
lages of the embryonic facial skeleton (Le Douarin andc-Myc MO was injected at the 16- or 32-cell stage and
C. Kalcheim, 1999; Hall and Ho¨rstadius, 1988), we furthertargeted only to the region of the ectoderm that normally
examined cartilage formation in c-Myc-depleted em-gives rise to neural crest cells. In contrast to experiments
bryos. When c-Myc MOs were injected into a singlein which c-Myc was depleted throughout larger regions
dorsal animal blastomere at the eight-cell stage, theof the nonneural ectoderm, expression of neural crest
resultant embryos were often found to lack recognizablemarkers was not always lost in embryos receiving tar-
cartilage on the injected side (n  17), while cartilagegeted injections. Instead, it was found that the expres-
formation on the contralateral side appeared normalsion of such genes had been shifted to a more lateral
(Figures 6Ci and 6Cii). Injections at later stages (16- orposition in the ectoderm, to a region where the cells
32-cell stage) or an incomplete inhibition of cranial neu-had not received c-Myc MO (Figure 5Fi; n  32, 45%).
ral crest precursors led to partial deletion of cartilagesBecause it was clear that the position of the neural
on the injected side (Figure 6Ciii; n  15). Overexpres-plate border had been shifted in these experiments, this
sion of c-Myc mRNA lacking the MO target sequencesuggested that the cells positioned medial to the new
was found to partially (42%, n 78) or completely (48%,
border, the cells that would normally have given rise to
n  78) rescue craniofacial defects in MO-injected em-
neural crest, had instead adopted an alternative fate.
bryos (data not shown). These results show that c-Myc is
As neural crest cells normally arise at the border be- required for the formation of the mesectodermal neural
tween the neural plate and the nonneural ectoderm, we crest precursors that give rise to the facial skeleton.
hypothesized that the myc-depleted cells had instead Cranial neural crest precursors also give rise to neu-
formed CNS precursors and that neighboring cells at rons and glia of the cranial sensory gangila (Le Douarin
the new border had been induced to form neural crest. and C. Kalcheim, 1999; Hall and Ho¨rstadius, 1988).
Consistent with this, expression of sox3, a pan-neural c-Myc-depleted embryos were allowed to develop to
marker (Penzel et al., 1997), was found to be expanded stage 28 and examined for expression of sox10, which,
on the injected side of these embryos into regions of at these stages, is expressed in glia in the CNS and
c-Myc depletion (Figure 6Dii; n 28, 85%). The observa- cranial ganglia (PNS) (Britsch et al., 2001; J.L. and C.L.,
tion that c-Myc-depleted cells switch from a neural crest unpublished data). No PNS expression of sox10 was
to a CNS fate indicates that, during normal development, detected on the injected side of c-Myc-depleted em-
this factor plays a central role in the determination of bryos, while the uninjected side showed characteristic
ectodermal cell fates at the neural plate border. expression of this gene in the developing trigeminal gan-
glia as well as the seventh, ninth, and tenth cranial gan-
c-Myc Depletion Results in Loss of Neural glia (Figure 7A; n  22). Similarly, n-tubulin expression
Crest Derivatives was observed in the developing cranial nerves on the
The observed loss of expression of early neural crest uninjected side of the embryo, but this expression was
absent on the c-Myc-depleted side (Figure 7B; n  29).markers in c-Myc-depleted embryos provides strong
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Figure 5. c-Myc Regulates Cell Fate Decisions at the Neural Plate Border
(A) phosphohistone H3 immunocytochemistry of c-Myc-depleted embryos. (i ) Transverse section through cranial neural folds of stage 14
embryos showing immunoreactive cells (dark blue nuclei) in regions receiving MO and lineage tracer -gal (light blue; left half of panel) versus
control regions (right half of panel). (ii) Close-up of a section showing individual mitotic -gal-positive nuclei. (iii) Percentage of total mitotic
nuclei in control and c-Myc-depleted regions of the sensorial ectoderm derived from 205 sections of 20 embryos. The number of mitotic cells
in these populations does not differ by more than 10% (p  0.001).
(B) Confocal micrograph of the neural crest-forming region of the sensorial ectoderm in a Xenopus embryo expressing a membrane-localized
variant of GFP. A subset of GFP-labeled cells was further injected with a mixture of rhodamine-conjugated dextran and c-Myc MOs. No
difference in size is noted between cells that did (red cytoplasm) or did not receive the MOs.
(C) Embryos treated with HUA from stage 11.5 showed a strong reduction in phosphohistone H3 staining at stage 19 (vii and viii) compared
to sibling embryos (iii and iv). This reduction was also noted at intermediate time points (data not shown). Expression of the neural crest
marker foxd3 is comparable in treated (v and vi) and untreated (i and ii) embryos.
c-Myc in Neural Crest Formation
835
Figure 6. c-Myc Depletion Results in a Loss of Neural Crest Derivatives
(A) Bilateral targeting of c-Myc MOs to trunk neural crest cells (i ) results in embryos with absent or reduced dorsal fins (white arrow) and
melanocytes (black arrowhead), but normal heads. When MOs are targeted to cranial regions (ii), dorsal fins (white arrow) and melanocytes
(black arrowhead) are normal, but cranial defects are observed.
(B) Embryo with targeted c-Myc depletion in cranial regions ([i], top) as compared to control embryo (bottom). Ventral view (ii) of face highlights
that developing branchial arches are present on the control side (black arrowhead), but absent on the depleted side (white arrowhead). Anterior
view (iii) similarly shows arch structures (black arrows) present only on control side. On the injected side, a mass of cells (black arrowhead)
is observed adjacent to the neural tube.
(C) Schematic (top left) depicting ventral cranial cartilages from stage 40 embryos that can be visualized after alcian blue staining (top right).
Facial skeletons dissected from c-Myc-depleted embryos lack all cartilages on the depleted side (i and ii), unless MOs are targeted to only
a subset of cranial neural crest cells (iii).
Expression of n-tubulin was normal in the CNS, however, of the neurogenic placodes, expression of six1 was
found to be inhibited on the injected side of c-Myc-further demonstrating that the effects of c-Myc deple-
tion are specific to tissues derived from cells shown to depleted embryos (Figure 7Ci; n  29). Interestingly,
however, the loss of precursors of both the neural crestexpress high levels of c-Myc transcripts at earlier stages
of development. Interestingly, a subset of neurons in and neurogenic placodes in c-Myc-depleted embryos
does not appear to reflect a complete loss of neuralthe cranial ganglia is presumed to be placodal in origin
(Baker and Bronner-Fraser, 2001). The absence of all plate border cell types. The expression of opl (also called
zic-1), a gene expressed in both neural crest and dorsalcranial sensory neurons in c-Myc-depleted embryos
suggests that c-Myc is required for the proper develop- CNS precursors (Kuo et al., 1998), was often found to
be expanded on the injected side of c-Myc-depletedment of the neurogenic placodes as well as neural crest.
Consistent with this, the initial domain of c-myc expres- embryos (Figure 7Cii; n  37, 54%,). Given the lack of
neural crest precursors in these embryos, this expandedsion at the neural plate border is wider than the subse-
quent expression domain of neural crest-specific genes, domain of opl expression is likely to reflect the expan-
sion of dorsal CNS precursors.such as slug, and extends into the region that will give
rise to the neurogenic placodes (Schlosser and North-
cutt, 2000; Figure 1D; data not shown). In order to further Discussion
characterize the role of c-Myc in the development of
this important cell type, which, like the neural crest, is Accumulating evidence indicates that neural crest for-
mation is a complex, multistep process. Although aa defining feature of vertebrate embryos, we examined
the expression of six1 in c-Myc-depleted embryos. six1 number of transcription factors have been reported to
be expressed in neural crest precursor cells, a clearis expressed at early neurula stages in cells of the primi-
tive placodal thickening, which includes the anlagen of molecular understanding of how these cells arise has
yet to emerge. Careful consideration of all available datathe neurogenic placodes (Ghanbari et al., 2001). Consis-
tent with a requirement for c-Myc in the development suggests that key regulators of neural crest formation
(D) Overexpression of the anti-apoptotic factor Bcl-xL is unable to rescue expression of slug in c-Myc-depleted embryos. Expression in doubly
injected embryos (ii) is comparable to expression in embryos receiving only the MOs (i ).
(E) Increased TUNEL labeling (dark purple) is not noted in -gal-expressing regions (light blue) of embryos injected with c-Myc MOs (i ) but
is noted in embryos injected with the apoptosis-inducing factor Dnmt3bl (ii).
(F) After c-Myc depletion in a more restricted region of the ectoderm, expression of slug is shifted laterally with respect to its normal position
(i ), while the expression of the neural marker sox-3 is expanded (ii). Injected sides are marked with arrowheads.
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of expression of downstream neural crest regulators
such as slug (Figure 1D) and is likely to include precur-
sors of the cranial sensory placodes (Schlosser and
Northcutt, 2000). Interestingly, it has previously been
reported that c-Myc is a downstream target of Wnt sig-
nals in colorectal tumors and embryonic carcinoma cells
(He et al., 1998; Willert et al., 2002), and we find here
that c-myc expression in the early ectoderm is depen-
dent upon prior Wnt signals. This suggests that the rela-
tionship between Wnt and c-Myc may be well con-
served.
Consistent with a role for c-Myc as a downstream
mediator of Wnt signals, our data demonstrate that
c-Myc is an essential early regulator of neural crest for-
mation. Using morpholino oligo-mediated depletion of
c-Myc protein, we found that c-Myc is required for the
expression of early neural crest markers such as slug,
foxd3, and twist. Interestingly, although injection of an
MO-resistant c-Myc isoform is able to rescue neural
crest formation in such embryos, injection of Slug can-
not. These data indicate that Slug, widely believed to
be a central mediator of neural crest formation, is not
alone sufficient to specify this cell type. Instead, at least
one or potentially multiple additional downstream tar-
gets of c-Myc must be required in order to specify neural
crest precursor fates. Work is currently underway to
elucidate the minimum number of downstream factors
required to rescue neural crest formation in c-Myc-
depleted embryos.
Although c-Myc was among the earliest oncogenes
identified, the mechanisms by which it mediates its ef-
fects had, until recently, remained somewhat enigmatic.Figure 7. c-Myc Depletion Prevents Formation of Cranial Sensory
All Myc family members possess a bHLHZ domain re-Ganglia
quired for dimerization and DNA binding. c-Myc can(A) sox10 expression in the glia of the trigeminal, seventh (VII), ninth
(IX), and tenth (X) cranial ganglia can be visualized on the control bind to E box DNA sequences after heterodimerization
(ii), but not the injected (i ), side of c-Myc-depleted embryos. E, the with the small bHLHZ protein Max, but it has been found
developing eye. to be a rather weak transcriptional activator. Instead, it
(B) n-tubulin expression in the CNS neurons (white arrow) can be appears from this work that c-Myc’s primary function is
seen on both the control (ii) and depleted (i ) side of the embryo,
to recruit histone acetyltransferases to target promotersbut n-tubulin expression in cranial sensory ganglia is seen only on
and that its biological activity is mediated mainly throughthe control side (ii).
control of histone H4 acetylation (Bouchard et al., 2001;(C) Loss of placodal six-1 expression on the injected side (arrow-
head) of c-Myc-depleted embryos (i ). Expanded expression of the Frank et al., 2001). Thus, c-Myc could function in this
neural plate border marker opl (zic1) on the injected side (arrowhead) way during neural crest development, allowing other
of c-Myc-depleted embryos (ii) shows that not all border cell fates regulatory factors to access promoters and activate
have been lost in these embryos. neural crest gene expression. It will be important to
determine which specific promoters c-Myc targets dur-
ing neural crest induction. Interestingly, several E box
have yet to be identified. This realization has led us to sequences are present in the Xenopus Slug promoter
search for factors that are expressed in the precursors of that could potentially serve as c-Myc binding sites (E.
neural crest cells from early stages of their development. Truesdell and C.L., unpublished data). In addition, there
c-myc is expressed in neural crest precursors at the are many examples in the literature of putative c-Myc
neural plate border from mid-gastrula stages, signifi- target genes that have been identified in cell culture
cantly before the onset of slug expression in this region. experiments, and a number of these could prove to be
Beginning at stage 11, c-myc expression is restricted important embryological targets as well. In particular,
to two populations of cells at the lateral edges of the Id2, which has been implicated in neural crest develop-
presumptive neural plate that correspond to the precur- ment (Martinsen and Bronner-Fraser, 1998), is a known
sors of the mandibular neural crest segments. In addi- myc target (Lasorella et al., 2002). There is also evidence
tion, somewhat weaker expression of c-myc is seen in that Myc family transcription factors may regulate the
cells along the anterior neural plate border in cells that expression of pax-3, a known regulator of neural crest-
will not contribute to the neural crest. In regions of the derived cell types (Harris et al., 2002).
neural plate border that will go on to form neural crest, c-Myc has previously been implicated in the regula-
c-myc expression is not initially restricted to neural crest tion of a number of diverse cellular processes, including
precursors. Instead, the domain of c-myc expression at proliferation, growth, differentiation, and programmed
cell death. Theoretically, if c-Myc were an importantneural plate stages is wider than the subsequent domain
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Experimental Proceduresregulator of the proliferation of neural plate border cells,
the loss of neural crest gene expression and, ultimately,
DNA Constructsneural crest derivatives in MO-injected embryos could
A partial Xenopus c-Myc cDNA was isolated from a stage 13–17
easily be attributed to a failure of a small group of precur- Xenopus cDNA library (gift of A. Zorn) that was arrayed with a Gen-
sors to proliferate. A number of lines of evidence argue etix robot (Caltech Genome Center) and screened with pools of
digoxigenin-labeled antisense cRNAs to identify clones expressedstrongly against this possibility. First, cells expressing
at early stages of neural crest development. The 5 end of the c-Mycthe lineage tracer -galactosidase are present in the
cDNA was isolated with a Smart RACE kit (Clontech). A full-lengthexpected numbers in c-Myc-depleted embryos, which
c-Myc cDNA was generated by low-cycle number PCR with a highis inconsistent with a failure of cells receiving the MOs
fidelity polymerase (Tgo; Boehringer Mannheim) and confirmed by
to proliferate. Furthermore, using three independent sequencing. The c-Myc cDNA used in this study is 98% identical
assays of cell division, we failed to detect a decrease to the c-MycII sequence previously reported by Vriz et al. (1989)
(accession number X14807). c-MycII was cloned into the vectorsin proliferation of c-Myc-depleted cells. Moreover, as
pCS2 and pCS2-MycC2 (gift of Robert Davis) for expression assays.the early stages of neural crest development proceed
cDNA clones corresponding to Xenopus c-Myc, c-MycI, L-Myc, andfairly normally in HUA-treated embryos (Figure 5C), a
N-Myc were also isolated by low-cycle number PCR and primersdecreased rate of cell proliferation could not explain the
based on the published sequences (X53717, X14806, X58670, and
dramatic loss of neural crest marker expression ob- L11362). For rescue experiments, a codon-substituted c-MycII
served in c-Myc-depleted embryos. Finally, we found cDNA that is translated in the presence of c-Myc MOs was generated
by low-cycle number PCR and with the upstream primer (5-ATGCCthat c-Myc-depleted cells that fail to express neural
GTTGAATGCAAACTTCCCTTCTAAGAACTACGACTAC).crest makers instead express sox3, a marker of CNS
fate. Thus, these data indicate that c-Myc plays an es-
Morpholino Assayssential role in cell fate decisions in the early ectoderm, The three pseudoallelic variants of c-Myc expressed in Xenopus
directing cells to form neural plate border cell types, have divergent 5 UTR sequences, but highly conserved coding
rather than neural plate. These findings do not altogether regions. In order to deplete all three c-Myc variants, morpholino
oligos designed to target a conserved region beginning at the trans-rule out a role for c-Myc in regulating cell proliferation,
lation-initiation site (5-TGGGAAAATTGGCGTTAAGAGGCAT) werehowever. Low levels of maternally derived c-Myc protein
obtained from Gene Tools. These oligos were found to inhibit c-Myccould persist in our depleted embryos and potentially
variants in IVT assays. For Western blot experiments, c-Myc tran-
play a role in cell cycle progression that is not revealed scripts were synthesized that contained the c-Myc MO target se-
by our morpholino knockdown experiments. Interest- quence and encoded full-length protein with a c-terminal Myc epi-
ingly, however, mutations in Drosophila c-Myc also fail tope tag. Embryos were injected with this RNA at the two-cell stage
and then subsequently reinjected with c-Myc MO or control MO atto cause defects in cell proliferation (Johnston et al.,
a dose of 1–10 ng/embryo. Embryos were collected at blastula or1999).
neurula stages and lysed in PBS/1% NP40, and extracts were re-While the present work clearly shows that c-Myc is solved by SDS PAGE. After immunoblotting with -Myc (9E10) anti-
required for neural crest specification downstream of bodies, labeled proteins were detected with HRP-conjugated sec-
Wnt signals, it also seems likely that c-Myc regulates ondary antibodies and enhanced chemiluminescence (Amersham).
For embryo experiments, 1 ng of c-Myc MO or 5 ng of control MOthe formation of other cell types that originate at the
(5-CCTCTTACCTCAGTTACAATTTATA) or N-Myc MO (5-GATTTCneural plate border. Our finding that the early expression
TGCTCACCAACCCTGGCAT) was injected in one animal blastomereof six1 at the neural plate border is lost and that
at the eight-cell stage, unless otherwise stated in the text.
n-tubulin-expressing cranial ganglia cells are absent in
c-Myc-depleted embryos strongly argues that at least Proliferation Assays
one additional border cell type, the neurogenic plac- For phosphohistone H3 detection, c-Myc MO-injected embryos
were fixed in formaldehyde at stage 13/14 and processed for -galodes, fails to form in these embryos. The expression
activity. -phosphohistone H3 antibody (Upstate Biotechnology)of c-myc in the presumptive tailbud precursors also
was used at a concentration of 5 g/ml; -rabbit IgG conjugatedsuggests a role for c-Myc in the development of these
with alkaline phosphatase (Boehringer Mannheim) was used at a
cells. In considering our findings in the context of previ- dilution of 1:1000 and was detected with BM purple. Stained em-
ous studies on the function of c-Myc in proliferating bryos were embedded in paraffin and sectioned at 10 m.
nonterminally differentiated cell types, it is tempting to -phosphohistone H3-positive nuclei in neural crest-forming regions
of the sensorial ectoderm were counted in equivalent regions on thespeculate that c-Myc could be commonly employed as
MO (-gal positive) and control sides of each section. To statisticallya strategy to prevent premature differentiation or cell
evaluate the effect of c-Myc-depletion on the number of mitoticfate decisions. In many cell types this role may be cou-
cells, we evaluated a total of 205 sections from 20 embryos. The
pled to cell cycle progression in a way that may be number of mitotic cells on both the MO and control sides was
unnecessary in early embryonic cells where proliferation individually summed for each embryo, and a nonparametric sign
is more “hardwired” and not dependent upon a source test was used to reject the null hypothesis that the number of mitotic
cells differed by more than 10% (p  0.001). For cell size compari-of mitogenic factors. Viewed in this way the expression
sons, embryos were injected at the two-cell stage with memGFP andof c-myc at the neural plate border makes considerable
then further injected in one cell at the 32-cell stage with rhodaminesense, as border cell types such as the neural crest
dextran (Molecular Probes) and c-Myc MO. At neural plate stages
must remain multipotent and unresponsive to signals 13–15, when premigratory neural crest cells are present at the neural
directing nearby cells to form epidermis or CNS precur- plate border, embryos or explanted neural folds were examined for
differences in the size of cells with or without the MO with a Leicasors. Alternatively, c-Myc could play a more instructive
confocal microscope. For HUA treatment, embryos were cultured inrole in the adoption of neural plate border fates. Whereas
0.1MMR with 20 mM hydroxyurea (Sigma) and 150M aphidocolinour results clearly demonstrate that c-Myc plays an es-
(Sigma) from stage 11.sential role in mediating cell fate decisions in the embry-
onic ectoderm, further elucidating the precise molecular Cell Death
mechanisms by which it does so remains a challenge Expression constructs encoding Dnmt3b1and hBcl-xL were ob-
tained from S. Tajimi and Y. Tujimoto. One hundred picograms offor the future.
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mRNA encoding Dnmt3b1and -gal was injected alone or with 1 ng formation of zebrafish neural crest by repressing Neurogenin 1 func-
tion. Development 129, 2639–2648.mRNA encoding hBcl-xL at the two-cell stage. To examine the ability
of hBcl-xL to rescue neural crest formation in c-Myc-depleted em- del Barrio, M.G., and Nieto, M.A. (2002). Overexpression of Snail
bryos, we injected embryos with -gal mRNA alone or together with family members highlights their ability to promote chick neural crest
hBcl-xL at the two-cell stage. Embryos were subsequently injected formation. Development 129, 1583–1593.
at the eight-cell stage with 2 ng c-Myc MO. Embryos were allowed
Deardorff, M.A., Tan, C., Saint-Jeannet, J.P., and Klein, P.S. (2001).to develop until stage 13, when they were processed for in situ
A role for frizzled 3 in neural crest development. Development 12,hybridization or TUNEL staining. TUNEL staining was carried out
3655–3663.by a protocol adapted from Hensey and Gautier (1998; J. Gautier,
Eisenman, R.N. (2001). Deconstructing myc. Genes Dev. 15, 2023–personal communication). Briefly, fixed embryos were rehydrated
2030.in PBT and washed in TdT buffer (Gibco) for 30 min. End labeling
was carried out at RT overnight in TdT buffer containing 0.5 M Essex, L.J., Mayor, R., and Sargent, M.G. (1993). Expression of
digoxygenin-dUTP (Boehringer Mannheim) and 150 U/ml TdT Xenopus Snail in mesoderm and prospective neural fold ectoderm.
(Gibco). Embryos were washed at 65C in PBS/1 m MEDTA, and Dev. Dyn. 198, 108–122.
detection of the digoxygenin epitope was carried out as for in situs.
Frank, S.R., Schroeder, M., Fernandez, P., Taubert, S., and Amati,
At neural plate stages 50% of control and MO-injected embryos
B. (2001). Binding of c-Myc to chromatin mediates mitogen-induced
showed some endogenous TUNEL staining, consistent with pub-
acetylation of histone H4 and gene activation. Genes Dev. 15, 2069–
lished reports (Hensey and Gautier, 1998).
2082.
Garcia-Castro, M.I., Marcelle, C., and Bronner-Fraser, M. (2002).Embryo Methods and Cartilage Staining
Ectodermal Wnt function as a neural crest inducer. Science 29,All results shown are representative of at least two independent
848–851.experiments. Collection, injection, and in situ hybridization of Xeno-
Ghanbari, H., Seo, H.C., Fjose, A., and Brandli, A.W. (2001). Molecu-pus embryos were as described (LaBonne and Bronner-Fraser,
lar cloning and embryonic expression of Xenopus Six homeobox1998). The Xenopus sox10 and foxD3 clones used for in situ experi-
genes. Mech. Dev. 101, 271–277.ments were isolated from an arrayed cDNA library essentially as
described for c-Myc. For cartilage staining, embryos were fixed in Grandori, C., Cowley, S.M., James, L.P., and Eisenman, R.N. (2000).
formaldehyde at stages 40–43 and stained overnight in 0.2% alcian The Myc/Max/Mad network and the transcriptional control of cell
blue/30% acetic acid in EtOH. Embryos were washed through a behavior. Annu. Rev. Cell Dev. Biol. 16, 653–699.
glycerol series into 80% glycerol/2% KOH before manual dissection
Hall, B.K., and Ho¨rstadius, S. (1988). The Neural Crest (Oxford: Ox-
of cartilages. RT-PCR analysis was as described (LaBonne and
ford University Press).
Bronner-Fraser, 1998).
Harris, W.A., and Hartenstein, V. (1991). Neuronal determination
without cell division in Xenopus embryos. Neuron 6, 499–515.
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